Why do we need more women leading cancer research? What specific challenges do women face and what are some strategies we can use to accelerate our careers in research & development? Is academia broken?
These are a few of the questions Eileen Faucher and Nora Disis discussed in their Linkedin Live conversation in April of 2022, in support of the American Cancer Society’s ResearcHERs campaign. To learn more about this campaign and how you can get involved, go here.
Dr. Disis is a renowned cancer researcher at the University of Washington, and one of the investigators who discovered HER-2/neu to be a tumor-specific marker. She currently directs the UW Medicine Cancer Vaccine Institute and serves as the Associate Dean of Translational Health Science and the Editor-in-Chief of JAMA Oncology.
